Company Filing History:
Years Active: 2018
Title: Shuyu Wang: Innovator in mTORC1 Modulation
Introduction
Shuyu Wang is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biomedical research, particularly in the modulation of mTORC1 activity. Her innovative work has implications for the treatment of various diseases characterized by aberrant mTORC1 activity.
Latest Patents
Shuyu Wang holds a patent titled "Methods for identifying compounds as modulators of SLC38A9 interactions." This invention relates to methods of identifying compounds that modulate mTORC1 activity in a cell by influencing the activity of SLC38A9 (NCBI Gene ID: 153129). The identified compounds can be utilized in the modulation of mTORC1 and in the treatment of diseases associated with abnormal mTORC1 activity. She has 1 patent to her name.
Career Highlights
Shuyu Wang is affiliated with the Whitehead Institute for Biomedical Research, where she conducts her research. Her work is at the forefront of understanding cellular mechanisms and developing therapeutic strategies.
Collaborations
Shuyu collaborates with notable scientists in her field, including David Sabatini and Zhi Tsun. These collaborations enhance the impact of her research and contribute to advancements in biomedical science.
Conclusion
Shuyu Wang's innovative contributions to the field of mTORC1 modulation highlight her role as a leading inventor in biomedical research. Her work not only advances scientific understanding but also holds promise for future therapeutic applications.